New research found over a quarter of children with treatment-refractory epilepsy sustained treatment response to CBD over four years.
Insights on Biohaven’s New Phase 2/3 Trial of Potassium Inhibitor BHV-7000 for Treating Focal Epilepsy
Episode 123: Previewing Cleveland Clinic's Epilepsy Summit
Efficacy of Oral Anticoagulants in Epilepsy and Atrial Fibrillation Not Impacted by Antiseizure Medications
Episode 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas
Angiotensin Receptor Blockers Tied to Decreased Risk of Epilepsy in Hypertension, Study Shows
Higher Burden of Epilepsy Reported Among Sexual and Gender Minoritized Patient Groups